IP Due Diligence Considerations for the Life Science Industry: What You Should Know
In recent years, evolving challenges in patenting inventions have continuously hounded the intellectual property (IP) landscape for life sciences companies. This current backdrop has been resulting to the growing number of companies pursuing deals and collaborations aimed at optimizing patent portfolios and protecting assets. In the midst of this intensifying industry trend, companies must be able to design and implement a cost-effective due diligence analysis to ensure success and mitigate pitfalls.
Listen as a panel of distinguished thought leaders organized by The Knowledge Group provide the audience with an in-depth discussion of significant IP due diligence considerations which life sciences companies should take. Speakers, among other things, will offer helpful insights in maximizing benefits and mitigating pitfalls in IP transactions in the aforementioned industry.
In a LIVE Webcast, the speakers will discuss:
- IP Due Diligence in the Life Science Industry: Statistics
- Key IP Due Diligence Considerations
- Implications of Recent Judicial Developments
- Integrated IP Strategy for Life Science Companies
- Best Compliance Practices
Theme: Best Practices for IP due Diligence for Life-Science Companies
- Importance of Understanding the Target Product
- Understanding Scope and Strength of a Patent Portfolio
- Issues Relating to Confirming IP Ownership
- Evaluating Third-party Patents and Applications
Greenberg Traurig LLP
- Info Gathering
- Document Review
IP Issues to Consider
- Key IP Assets
- Scope of IP Schedule
- Ownership/Right to Use
- Licensing/Controlling IP Prosecution
- Timing for Additional IP Filing
Who Should Attend:
- IP Attorneys & Related Attorneys
- Trademark Attorneys
- Patent Licensing Attorneys
- Patent Litigators
- Patent Owners
- Licensing Professionals
- Senior Management
- Life Science Industry Companies
Andrew Wasson is a partner in the New York office of Haug Partners. Andrew has a broad range of experience in both the brand and generic side of pharmaceuticals, especially with respect to issues involving intellectual property law and regulatory law. Having grown up with a father who is a patent lawyer, Mr. Wasson has been involved in patents in one way or another for the better part of his life and has the advantage of being able to deal with complex patent law concepts in a very natural way. Mr. Wasson is registered to practice before the U.S. Patent and Trademark Office and has published extensively in both scientific and legal literature. Mr. Wasson also serves on the Editorial Advisory Board for FDLI's Update Magazine.
Andrew Wasson is a partner in the New York office of Haug Partners. Andrew has a broad range of experience …
Chinh H. Pham is chair of Greenberg Traurig’s Emerging Technology Group and co-chair of the firm’s Intellectual Property (IP) Group in Boston. Chinh counsels tech clients and assists them in protecting their innovation, in leveraging and monetizing their IP portfolio and in positioning the company for commercial success. He is also a mentor to entrepreneurs and start-ups through many incubator and accelerator programs, and serves as an Attorney-in-Residence at Harvard’s Innovation Lab and Northwestern The Garage, where he advises student entrepreneurs on their business ventures. Chinh is an Executive Committee member and treasurer of the Boston Bar Association, and chair of the Board of Overseers of Boston Museum of Science. Chinh was named a "Technology Law Trailblazer," by National Law Journal, and a “Top Emerging Tech Lawyer” by TechCrunch.
Chinh H. Pham is chair of Greenberg Traurig’s Emerging Technology Group and co-chair of the firm’s Intellectual Property (IP) Group …
Print and review course materials
Method Of Presentation:
General knowledge of intellectual property law
NY Category of CLE Credit:
Areas of Professional Practice
Unlock All The Knowledge and Credit You Need
Leading Provider of Online Continuing Education
It's As Easy as 1, 2, 3
UNLIMITED 1 Year Pass for only $199
About Haug Partners
Haug Partners is a full-service, national law firm that provides integrated multidisciplinary legal services for life science and technology companies. Our service offerings include: (i) Antitrust Litigation and Counseling; (ii) Commercial Litigation and Strategic Counseling; (iii) Due Diligence; (iv) FDA Compliance and Counseling; (v) Intellectual Property Enforcement; (vi) Intellectual Property Procurement and Strategy; (vii) International Trade Commission; (viii) Investigations, Compliance, and Risk Mitigation Services; (ix) Licensing and Transactions; and (x) Trademarks and Unfair Competition. With offices in New York, Washington, D.C., and Boston, and through relationships with firms in Germany, China, Japan, and other key international markets, Haug Partners has the resources, technical expertise, legal acumen, and business judgment to consistently deliver optimal outcomes for clients.
About Greenberg Traurig LLP
Greenberg Traurig, LLP (GT) has approximately 2100 attorneys in 41 locations in the United States, Latin America, Europe, Asia, and the Middle East. GT has been recognized for its philanthropic giving, diversity, and innovation, and is consistently among the largest firms in the U.S. on the Law360 400 and among the Top 20 on the Am Law Global 100. Web: http://www.gtlaw.com Twitter: @GT_Law.